Clinical trial Recruiting at 1 site Observational Ages 18 and up

Evaluating treatment quality for adults with heart attacks in China

Official title: Clinical Performance and Quality Measures for Adults With Acute ST-Elevation Myocardial Infarction in China

Run by China National Center for Cardiovascular Diseases · NCT04088682 · Data updated 2026-11-12

This study is trying to see how well hospitals in China are treating adults who have heart attacks to help improve their care and outcomes.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment200000 (estimated)
SponsorChina National Center for Cardiovascular Diseases
Government
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedJuly 15, 2018
Main results expectedDecember 31, 2035
Study endsDecember 31, 2035
Registry record updatedOctober 9, 2019
Trial IDNCT04088682 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults diagnosed with STEMI who arrive at the hospital within 48 hours of symptom onset.

Probably not a fit

Patients who do not present with STEMI or arrive at the hospital after 48 hours from symptom onset may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates clinical performance and quality measures for adults experiencing acute ST-elevation myocardial infarction (STEMI) in China. It involves the annual recruitment of eligible inpatients to collect medical information and assess the performance of participating hospitals. The study aims to develop quality improvement strategies and tools that focus on enhancing treatment and clinical outcomes for STEMI patients. By comparing reperfusion rates and other performance measures annually, the study seeks to generate new knowledge about STEMI management in China.

Why it matters

Potential benefit: If successful, this study could lead to improved treatment protocols and outcomes for patients suffering from STEMI.

How similar studies have gone: Other studies have shown success in improving clinical outcomes through quality improvement strategies in cardiovascular care, indicating that this approach has potential.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with STEMI who arrive at the hospital within 48 hours from the symptoms onset.

Exclusion Criteria:

* None

Where it's running

  • Hongjian Wang
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.